(Q39427542)

11 September 2017

title

Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma (English)

1 reference

11 September 2017

1 reference

N Rainusso

1

1 reference

11 September 2017

V S Brawley

2

1 reference

11 September 2017

A Ghazi

3

1 reference

11 September 2017

M J Hicks

4

1 reference

11 September 2017

S Gottschalk

5

1 reference

11 September 2017

J M Rosen

6

1 reference

11 September 2017

N Ahmed

7

1 reference

11 September 2017

publication date

16 December 2011

1 reference

11 September 2017

1 reference

11 September 2017

volume

19

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

212-217

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2011.83

11 September 2017

exact match

0 references

cites work

Biology and therapeutic advances for pediatric osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Targeting the osteosarcoma cancer stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

The increasing complexity of the cancer stem cell paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Detection and characterization of CD133+ cancer stem cells in human solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Stem-like cells in bone sarcomas: implications for tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Identification of tumor-initiating cells in a p53-null mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Cancer stem cells: a step toward the cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

inferred from DOI database lookup

7 January 2021

based on heuristic

Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.83

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2011.83

1 reference

Dimensions Publication ID

11 September 2017

1008130459

0 references

1 reference